121 related articles for article (PubMed ID: 7513588)
1. Suppression of the antivenom antibody response by serum therapy.
Cardoso DF; Moura-da-Silva AM; Mota I
Braz J Med Biol Res; 1994 Jan; 27(1):33-41. PubMed ID: 7513588
[TBL] [Abstract][Full Text] [Related]
2. Phenol used as a preservative in Bothrops antivenom induces impairment in leukocyte-endothelial interactions.
Zychar BC; Castro NC; Marcelino JR; Gonçalves LR
Toxicon; 2008 Jun; 51(7):1151-7. PubMed ID: 18343474
[TBL] [Abstract][Full Text] [Related]
3. Linear B-cell epitopes in BthTX-1, BthTX-II and BthA-1, phospholipase A₂'s from Bothrops jararacussu snake venom, recognized by therapeutically neutralizing commercial horse antivenom.
De-Simone SG; Napoleão-Pego P; Teixeira-Pinto LA; Santos JD; De-Simone TS; Melgarejo AR; Aguiar AS; Marchi-Salvador DP
Toxicon; 2013 Sep; 72():90-101. PubMed ID: 23792452
[TBL] [Abstract][Full Text] [Related]
4. Experimental antivenom against serine proteases from the Bothrops jararaca venom obtained in mice, and its comparison with the antibothropic serum from the Butantan Institute.
Kuniyoshi AK; Kodama RT; Cajado-Carvalho D; Iwai LK; Kitano E; da Silva CCF; Duzzi B; Dias da Silva W; Portaro FC
Toxicon; 2019 Nov; 169():59-67. PubMed ID: 31494207
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing potency of horse antibothropic Brazilian antivenom against Bothrops snake venoms from the Amazonian rain forest.
Muniz EG; Maria WS; Estevão-Costa MI; Buhrnheim P; Chávez-Olórtegui C
Toxicon; 2000 Dec; 38(12):1859-63. PubMed ID: 10858523
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of the efficacy of antivenom injection at the site of the intramuscular inoculation of Bothrops jararaca venom: experimental study in mice].
Utescher CL; Vieira SL; Fensterseifer S; Ribeiro LA; Jorge MT
Rev Inst Med Trop Sao Paulo; 1994; 36(3):275-8. PubMed ID: 7855492
[TBL] [Abstract][Full Text] [Related]
7. Detection and neutralization of B. jararaca venom in mice.
Domingos MO; Takehara HA; Laing G; Snowden KF; Sells PG; Mota I; Theakston RD
Braz J Med Biol Res; 1994 Nov; 27(11):2613-22. PubMed ID: 7549984
[TBL] [Abstract][Full Text] [Related]
8. Lachesis stenophrys venom reduces the equine antibody response towards Bothrops asper venom used as co-immunogen in the production of polyspecific snake antivenom.
Arroyo C; Solano S; Herrera M; Segura Á; Estrada R; Vargas M; Villalta M; Gutiérrez JM; León G
Toxicon; 2015 Sep; 103():99-105. PubMed ID: 26100664
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing potency of horse antibothropic antivenom. Correlation between in vivo and in vitro methods.
Maria WS; Cambuy MO; Costa JO; Velarde DT; Chávez-Olórtegui C
Toxicon; 1998 Oct; 36(10):1433-9. PubMed ID: 9723841
[TBL] [Abstract][Full Text] [Related]
10. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.
León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM
Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538
[TBL] [Abstract][Full Text] [Related]
11. Immunization of horses with Crotalus durissus terrificus (South American rattlesnake) venom. A comparison of four different procedures.
Freitas TV; Fortes-Dias CL; Diniz CR; Velarde DT; Freitas CF
Braz J Med Biol Res; 1991; 24(3):281-90. PubMed ID: 1823242
[TBL] [Abstract][Full Text] [Related]
12. [Cross neutralization of bothrops jararacussu venom by heterologous antivenoms].
de Roodt AR; Vidal JC; Litwin S; Dokmetjian JC; Dolab JA; Hajos SE; Segré L
Medicina (B Aires); 1999; 59(3):238-42. PubMed ID: 10451561
[TBL] [Abstract][Full Text] [Related]
13. Development of an ELISA to assess the potency of horse therapeutic polyvalent antibothropic antivenom.
Heneine LG; Carvalho AD; Barbosa CF; Arávjo dos Santos MR
Toxicon; 1998 Oct; 36(10):1363-70. PubMed ID: 9723835
[TBL] [Abstract][Full Text] [Related]
14. Effect of dexamethasone associated with serum therapy on treatment of Bothrops jararaca venom-induced paw edema in mice.
Araújo SD; de Souza A; Nunes FP; Gonçalves LR
Inflamm Res; 2007 Oct; 56(10):409-13. PubMed ID: 18026697
[TBL] [Abstract][Full Text] [Related]
15. Production of monovalent anti-Bothrops asper antivenom: development of immune response in horses and neutralizing ability.
Gutiérrez JM; Chaves F; Rojas E; Elizondo J; Avila C; Cerdas L
Rev Biol Trop; 1988 Nov; 36(2B):511-7. PubMed ID: 3078800
[TBL] [Abstract][Full Text] [Related]
16. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy.
Rivière G; Choumet V; Audebert F; Sabouraud A; Debray M; Scherrmann JM; Bon C
J Pharmacol Exp Ther; 1997 Apr; 281(1):1-8. PubMed ID: 9103473
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of IgG and F(ab')2 antivenoms to neutralize snake venom-induced local tissue damage as assessed by the proteomic analysis of wound exudate.
Rucavado A; Escalante T; Shannon JD; Ayala-Castro CN; Villalta M; Gutiérrez JM; Fox JW
J Proteome Res; 2012 Jan; 11(1):292-305. PubMed ID: 22004524
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of venom and antivenom serum and clinical parameters and treatment efficacy in Bothrops alternatus envenomed dogs.
Jacome D; Melo MM; Santos MM; Heneine LG
Vet Hum Toxicol; 2002 Dec; 44(6):334-8. PubMed ID: 12458635
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: implications for the production of polyspecific snake antivenoms.
Dos-Santos MC; Arroyo C; Solano S; Herrera M; Villalta M; Segura A; Estrada R; Gutiérrez JM; León G
Toxicon; 2011 Feb; 57(2):237-43. PubMed ID: 21130107
[TBL] [Abstract][Full Text] [Related]
20. Oral Tolerance Induction by
Tsuruta LR; Moro AM; Tambourgi DV; Sant'Anna OA
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
